Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Max Healthcare Institute Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹1,067.00
High
₹1,083.10
Price Summary
| Previous Close | ₹1,083.00 |
|---|---|
| Day's Range | ₹1,067.00 - ₹1,083.10 |
| Open | ₹1,070.00 |
| 52 Week Range | ₹903.00 - ₹1,301.70 |
| Volume | 1,68,689 |
| Market Cap | ₹0.10 |
| Previous Close | ₹1,080.95 |
|---|---|
| Day's Range | ₹1,062.25 - ₹1,082.85 |
| Open | ₹1,062.25 |
| 52 Week Range | ₹903.50 - ₹1,301.95 |
| Volume | 81,929 |
| Market Cap | ₹0.10 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 1,826.90 |
|---|---|
| Market Cap (₹ in Mn) | 0.10 |
| Dividend Yield(%) | 0.19 |
| Price/Earning (TTM) | 72.54 |
| TTM EPS (₹) | 14.82 |
| P/E Ratio | 64.88 |
| Book Value(₹) | 9.87 |
| PAT Margin (%) | 17.23 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 14.97 |
| Trade Value ( ₹ in Lacs) | 885.61 |
|---|---|
| Market Cap (₹ in Mn) | 0.10 |
| Dividend Yield(%) | 0.19 |
| Price/Earning (TTM) | 72.54 |
| TTM EPS (₹) | 14.82 |
| P/E Ratio | 64.88 |
| Book Value(₹) | 9.87 |
| PAT Margin (%) | 17.23 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 14.97 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 26636.0 | 6587.0 |
| Expenses | N/A | N/A |
| PBT | 9467.2 | 2272.3 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 7010.7 | 1773.9 |
About Max Healthcare Institute Ltd.
| Founded | 2001 |
|---|---|
| Managing Director | Abhay Soi |
| NSE Symbol | MAXHEALTH |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,66,430.72 | 1,948.40 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,20,114.60 | 8,322.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,88,852.64 | 4,951.60 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,26,715.98 | 8,972.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,19,158.34 | 1,468.00 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,10,348.86 | 1,105.95 | 835.50 - 835.50 |
| Lupin Ltd. | 1,09,347.72 | 2,389.75 | 1,855.00 - 1,855.00 |
| Max Healthcare Institute Ltd. | 1,04,626.89 | 1,080.95 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,00,395.19 | 2,428.00 | 1,909.70 - 1,909.70 |
| Laurus Labs Ltd. | 99,201.32 | 1,845.55 | 810.05 - 810.05 |
No Records Found
Latest News
Jul
8
2026
Posted on Jul 8th 2026
Max Healthcare Institute informs about disclosure
Max Healthcare Institute has informed that this is in continuation to the earlier intimation dated May 19, 2026, regarding ongoing litigation against Kalinga Hospital (KHL), a subsidiary of the Company, other shareholder of KHL from whom the Company acquired the majority equity stake, including the Company under section 241 and 242 of the Companies Act, 2013. Subsequently, an interlocutory petition has been filed before the Hon’ble National Company Law Tribunal, Cuttack Bench (NCLT) by legal representatives of BRS Capital Two Pte. Limited requesting stay on the Postal Ballot Notice dated May 29, 2026 issued by KHL in relation to increasing borrowing limits and creating charge on assets of the Company. The said petitions were listed before the NCLT on July 7, 2026 at 11.30 am (IST). Details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. This disclosure will also be hosted on Company's website, www.maxhealthcare.in.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
20
2026
Posted on Jun 20th 2026
Max Healthcare Institute informs about AGM & record date
Max Healthcare Institute has informed about the following with respect to Annual General Meeting, Record Date and Communication sent to members for deduction of tax at source on final dividend: 1) Annual General Meeting: The Twenty-Fifth Annual General Meeting (‘AGM’) of members of the Company is scheduled to be held on Thursday, July 30, 2026 through video conference / other audio-visual means, in accordance with the applicable circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India (‘SEBI’). 2) Record Date: Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, July 3, 2026, as the ‘Record Date’ for determining the members entitled to receive the final dividend for the financial year 2025-26, if approved by members at the ensuing 25th AGM. 3) Communication to member for deduction of tax at source on final dividend: The Company has today, June 19, 2026, sent a detailed communication to all members of the Company, whose e-mail addresses are registered with the Company/ depositories, indicating the process and documentation required for claiming exemption from deduction of tax at source on final dividend for the financial year 2025-26, which is subject to the approval of members at the ensuing 25th AGM. A copy of e-mail communication sent to members is enclosed as Annexure. This disclosure will also be hosted on Company's website: www.maxhealthcare.in.
The above information is a part of company’s filings submitted to BSE.
Read More
May
20
2026
Posted on May 20th 2026
Max Healthcare Institute informs about grant of stock options
Max Healthcare Institute has informed that Nomination and Remuneration Committee (NRC) of the Company in its meeting held today i.e. May 20, 2026, has approved the grant of 2,15,000 stock options to eligible employees under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. Details pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure. The NRC meeting commenced at 12.15 pm (IST) and concluded at 1.00 pm (IST). This disclosure will also be hosted on Company's website viz. www.maxhealthcare.in.
The above information is a part of company’s filings submitted to BSE.
Read More
Aug
7
2026
Posted on Aug 7th 2026
Procter&Gamble Healt - Quaterly Results
The Revenue for the quarter ended June 2026 of Rs. 3637.10 millions grew by 7.37 % from Rs. 3387.40 millions.Net Profit recorded in the quarter ended June 2026 rise to 45.29% to Rs. 961.50 millions compared to R. 661.80 millions in corresponding previous quarter.Operating profit for the quarter ended June 2026 rose to 1034.80 millions as compared to 943.70 millions of corresponding quarter ended June 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 3637.10 | 3387.40 | 7.37 | 3637.10 | 3387.40 | 7.37 | 14079.70 | 0.00 | 0.00 |
| Other Income | 38.80 | 40.30 | -3.72 | 38.80 | 40.30 | -3.72 | 173.40 | 0.00 | 0.00 |
| PBIDT | 1034.80 | 943.70 | 9.65 | 1034.80 | 943.70 | 9.65 | 4740.00 | 0.00 | 0.00 |
| Interest | 1.40 | 1.20 | 16.67 | 1.40 | 1.20 | 16.67 | 5.50 | 0.00 | 0.00 |
| PBDT | 1351.40 | 942.50 | 43.38 | 1351.40 | 942.50 | 43.38 | 4734.50 | 0.00 | 0.00 |
| Depreciation | 60.20 | 54.40 | 10.66 | 60.20 | 54.40 | 10.66 | 235.90 | 0.00 | 0.00 |
| PBT | 1291.20 | 888.10 | 45.39 | 1291.20 | 888.10 | 45.39 | 4498.60 | 0.00 | 0.00 |
| TAX | 329.70 | 226.30 | 45.69 | 329.70 | 226.30 | 45.69 | 1229.50 | 0.00 | 0.00 |
| Deferred Tax | 19.40 | -3.10 | -725.81 | 19.40 | -3.10 | -725.81 | 44.60 | 0.00 | 0.00 |
| PAT | 961.50 | 661.80 | 45.29 | 961.50 | 661.80 | 45.29 | 3269.10 | 0.00 | 0.00 |
| Equity | 166.00 | 166.00 | 0.00 | 166.00 | 166.00 | 0.00 | 166.00 | 0.00 | 0.00 |
| PBIDTM(%) | 28.45 | 27.86 | 2.13 | 28.45 | 27.86 | 2.13 | 33.67 | 0.00 | 0.00 |
Read More
Aug
7
2026
Posted on Aug 7th 2026
Zim Laboratories - Quaterly Results
The sales moved up 30.27% to Rs. 930.48 millions for the June 2026 quarter as compared to Rs. 714.28 millions during the year-ago period.The Net Loss for the quarter ended June 2026 is Rs. -38.74 millions as compared to Net Loss of Rs. -16.93 millions of corresponding quarter ended June 2025Operating Profit reported a sharp decline to 33.93 millions from 58.10 millions in the corresponding previous quarter.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 930.48 | 714.28 | 30.27 | 930.48 | 714.28 | 30.27 | 3704.82 | 3756.36 | -1.37 |
| Other Income | 9.86 | 14.76 | -33.20 | 9.86 | 14.76 | -33.20 | 113.90 | 56.21 | 102.63 |
| PBIDT | 33.93 | 58.10 | -41.60 | 33.93 | 58.10 | -41.60 | 409.70 | 488.90 | -16.20 |
| Interest | 36.43 | 33.04 | 10.26 | 36.43 | 33.04 | 10.26 | 132.02 | 113.86 | 15.95 |
| PBDT | -2.50 | 25.06 | -109.98 | -2.50 | 25.06 | -109.98 | 277.68 | 375.04 | -25.96 |
| Depreciation | 51.71 | 47.90 | 7.95 | 51.71 | 47.90 | 7.95 | 193.67 | 198.91 | -2.63 |
| PBT | -54.21 | -22.84 | 137.35 | -54.21 | -22.84 | 137.35 | 84.01 | 176.13 | -52.30 |
| TAX | -15.47 | -5.91 | 161.76 | -15.47 | -5.91 | 161.76 | 24.35 | 58.68 | -58.50 |
| Deferred Tax | -15.47 | -5.91 | 161.76 | -15.47 | -5.91 | 161.76 | -8.40 | 14.21 | -159.11 |
| PAT | -38.74 | -16.93 | 128.82 | -38.74 | -16.93 | 128.82 | 59.66 | 117.45 | -49.20 |
| Equity | 535.49 | 487.26 | 9.90 | 535.49 | 487.26 | 9.90 | 535.00 | 487.26 | 9.80 |
| PBIDTM(%) | 3.65 | 8.13 | -55.17 | 3.65 | 8.13 | -55.17 | 11.06 | 13.02 | -15.03 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Max Healthcare Institute Ltd. is ₹1,083.00 as of 2026-08-07.
The market capitalisation of Max Healthcare Institute Ltd. is ₹104,626.89 as of 2026-08-06.
The 1-year return of Max Healthcare Institute Ltd. is -188.10% as of 2026-08-07.
The P/E ratio of Max Healthcare Institute Ltd. is 64.88 as of 2026-08-07.
The 52-week high and low of Max Healthcare Institute Ltd. are ₹1,301.70 and ₹903.00, respectively, as of 2026-08-07.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
